Should Cloning be Used for “De-Extinction”?
By John R. Platt,
Scientific American
| 03. 06. 2013
At some point in the next decade, if advances in biotechnology continue on their current path, clones of extinct species such as the passenger pigeon, Tasmanian tiger and wooly mammoth could once again live among us. But cloning lost species—or “de-extinction” as some scientists call it—presents us with myriad ethical, legal and regulatory questions that must be answered, such as which (if any) species should be brought back and whether or not such creatures could be allowed to return to the wild. Such questions are set to be addressed March 15 at
TEDx DeExtinction, a day-long event in Washington, D.C., organized by Stewart Brand’s
Revive & Restore project. Brand previewed the topics for discussion last week at the
TED2013 conference in Long Beach, Calif.
Scientists are actively working on methods and procedures for bringing extinct species back to life, says Ryan Phelan, executive director of Revive & Restore and co-organizer of the TEDx event. “The technology is moving fast. What Stewart and I are trying to do with this meeting is for the first time to allow the public...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...